Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...
Conditions: Exercise; Physical Activity; Accidental Fall; Motivation; Older Adults Interventions: Behavioral: Otago Exercise Program; Device: Physical activity monitors (e.g., Fitbit); Behavioral: Interpersonal Behavior Change Strategies; Behavioral: Intrapersonal Behavior Change Strategies; Other: Information about Health and Wellness Sponsors: University of Minnesota; National Institute of Nursing Research (NINR) Recruiting
Condition: Mild Cognitive Impairment Interventions: Behavioral: ACT; Behavioral: Cycling Only; Behavioral: Cognitive Training Only; Behavioral: Stretching and Mental Stimulating Activities Sponsors: University of Minnesota; University of Rochester; Mayo Clinic; University of St Thomas Recruiting
Conditions: Dupuytren's Disease; Dupuytren Contracture; Dupuytren Disease of Palm and Finger; Dupuytren Disease of Finger; Dupuytrens Contracture of Both Hands; Dupuytren's Disease of Palm of Right Hand; Dupuytren's Disease of Palm of Left Hand; Dupuytren Contracture of Right Palm; Dupuytren Contracture of Left Palm; Dupuytren's Contracture Left; Dupuytren's Contracture Right Intervention: Other: Evaluation of Dupuytren's Disease Treatment Sponsor: University of Minnesota Recruiting
Conditions: Stroke; Quality of Life; Depression Interventions: Behavioral: Problem-Solving Therapy; Other: Stroke-Related Health Education Sponsors: Allina Health System; University of Minnesota Recruiting
Conditions: Post-Traumatic Stress Disorders; Major Depressive Disorder Interventions: Drug: Ketamine; Other: Normal Saline Sponsors: University of Minnesota; Minneapolis Veterans Affairs Medical Center Recruiting
Condition: Type1diabetes Interventions: Drug: Regular insulin (Humulin-R), intranasal route; Device: SipNose intranasal device Sponsors: HealthPartners Institute; International Diabetes Center at Park Nicollet; Juvenile Diabetes Research Foundation Recruiting
Conditions: TN ER-/PR-/HER2- Breast Cancer; Triple Negative Breast Cancer; HER2-positive Breast Cancer; ERany/PRany/HER2+ Breast Cancer Intervention: Radiation: Standard Trimodality Breast Imaging Sponsor: Masonic Cancer Center, University of Minnesota Recruiting
Condition: Prostate Cancer Interventions: Drug: Cabazitaxel; Drug: Carboplatin; Drug: Abiraterone; Drug: Prednisone Sponsor: Masonic Cancer Center, University of Minnesota Recruiting
Conditions: Health Knowledge, Attitudes, Practice; Training Intervention: Behavioral: Health Curriculum Training Sponsors: University of Minnesota; Muhimbili University of Health and Allied Sciences; Johns Hopkins University Recruiting
Conditions: Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Carcinoma Intervention: Sponsors: University of Minnesota; United States Department of Defense Recruiting
Conditions: Dementia; Alzheimer Disease; Memory Loss Interventions: Behavioral: Care to Plan; Behavioral: Usual Care Sponsors: University of Minnesota; National Institute on Aging (NIA) Recruiting
Conditions: Chronic Pancreatitis; Diabetes Mellitus; Islet Cell Transplantation Interventions: Procedure: Intrahepatic islets and islets in the omental pouch; Procedure: Intrahepatic islets alone; Other: Normal Volunteers Sponsor: University of Minnesota Recruiting
Conditions: SRP; Minocycline HCl Microspheres; Biomarkers Intervention: Drug: minocycline HCl microspheres Sponsors: University of Minnesota; Bausch Health Companies, INC. Recruiting
Condition: Bloodstream Infection Interventions: Diagnostic Test: Accelerate PhenoTest™ BC kit; Diagnostic Test: Standard of Care Sponsor: Accelerate Diagnostics, Inc. Recruiting
Condition: Smoking Interventions: Drug: Indole-3-Carbinol; Drug: Silibinin; Drug: Silibin Sponsor: Masonic Cancer Center, University of Minnesota Recruiting
Conditions: Active tDCS; Sham tDCS Interventions: Device: Transcranial direct current stimulation; Device: Sham transcranial direct current stimulation Sponsor: University of Minnesota Recruiting
Condition: Hypertension Intervention: Behavioral: mGlide Sponsors: University of Minnesota; National Heart, Lung, and Blood Institute (NHLBI) Recruiting
Condition: Allogeneic HCT Survivors Interventions: Other: 10 Weeks of Strength Trailing; Other: Group Nutrition Discussion: week 1, week 5 and week 10 Sponsor: Masonic Cancer Center, University of Minnesota Recruiting
Conditions: Acute Coronary Syndrome; Tobacco Use Interventions: Behavioral: BAT-CS; Behavioral: Smoking Cessation and Health & Wellness Sponsors: Hennepin Healthcare Research Institute.; Minneapolis Heart Institute Foundation; The Miriam Hospital; National Heart, Lung, and Blood Institute (NHLBI); University of Minnesota Recruiting
Condition: Traumatic Brain Injury Intervention: Diagnostic Test: Continuous electrocorticography post severe traumatic brain injury requiring neurosurgical intervention Sponsor: Hennepin County Medical Center, Minneapolis Recruiting
Condition: Chronic Stroke Intervention: Behavioral: Selective Control Assessment of Lower Extremity (SCALE) Sponsor: University of Minnesota Recruiting
Conditions: HIV/AIDS; Menopause; Inflammation Vagina Interventions: Drug: Tenofovir; Drug: Emtricitabine Sponsors: University of Minnesota; American College of Clinical Pharmacy Recruiting
Conditions: Epithelial Ovarian Cancer; Fallopian Tube Cancer; Primary Peritoneal Cancer Interventions: Biological: FATE-NK100; Drug: Interleukin-2 Sponsor: Masonic Cancer Center, University of Minnesota Recruiting
Condition: Refractory Respiratory Failure Interventions: Other: Open-Chain Leg Exercise; Device: Closed-Chain Leg Exercise Sponsor: University of Minnesota Recruiting
Conditions: Alcohol Use Disorder; Anxiety Disorder/Anxiety State; Stress Disorder; Hypothalamic Pituitary Adrenal; Drinking to Cope Intervention: Sponsors: University of Minnesota; National Institute on Alcohol Abuse and Alcoholism (NIAAA) Recruiting
Conditions: FIGO Stage III and IV Ovarian Cancer; FIGO Stage III and IV Fallopian Tube Cancer; FIGO Stage III Primary Peritoneal Cancer Interventions: Biological: ALT-803 Subcutaneous; Biological: ALT-803 Intraperitoneal Sponsor: Masonic Cancer Center, University of Minnesota Recruiting
Condition: Clostridium Difficile Infection Interventions: Drug: Fecal Microbiota Therapy (FMT); Drug: Placebo Sponsor: VA Office of Research and Development Recruiting
Conditions: Acute Myelogenous Leukemia (AML); Myelodysplastic Syndrome (MDS) Intervention: Drug: N-803 Sponsor: Masonic Cancer Center, University of Minnesota Recruiting
Conditions: Musculoskeletal Pain; Fractures, Closed; Distal Radius Fracture; Complex Regional Pain Syndromes Interventions: Behavioral: Standard Care; Behavioral: Motor Representation Techniques Sponsors: University of Minnesota; American Hand Therapy Foundation; Fairview Health Services Recruiting
Conditions: Alzheimer Disease; Dementia Intervention: Behavioral: The Residential Care Transition Module Sponsors: University of Minnesota; Johns Hopkins University; NYU Langone Health; Benjamin Rose Institute; Emory University Recruiting
Condition: Pancreatitis, Chronic; Diabetes; Transplant Interventions: Drug: etanercept; Drug: Alpha 1-Antitrypsin Sponsors: University of Minnesota; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Condition: Peripheral Arterial Disease Interventions: Drug: Entresto; Drug: Placebo group Sponsors: University of Minnesota; American Heart Association Recruiting
Condition: Chronic Obstructive Pulmonary Disease Interventions: Drug: Chlorhexidine; Other: Placebo Sponsors: University of Minnesota; Veterans Medical Research Foundation; Flight Attendant Medical Research Institute Recruiting
Condition: Heart Failure, Systolic Intervention: Device: Reprogramming of CRT Device Settings to Optimal Electrical Synchrony Sponsor: Allina Health System Recruiting
Condition: Chronic Total Occlusion of Coronary Artery Intervention: Device: SoundBite™ Crossing System Active Wire 14 Sponsors: SoundBite Medical Solutions, Inc.; ethica Clinical Research Inc.; Cardiovascular Research Foundation, New York Recruiting
Condition: Gaucher Disease Type 1 Intervention: Drug: N-acetylcysteine Sponsors: University of Minnesota; Rare Diseases Clinical Research Network; National Center for Advancing Translational Science (NCATS); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Neurological Disorders and Stroke (NINDS); Lysosomal Disease Network Recruiting
Condition: Type 2 Diabetes Interventions: Behavioral: Diet Beverage; Behavioral: Water Sponsors: University of California, Irvine; University of Minnesota; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Condition: Alcohol Use Disorder Intervention: Behavioral: Brief Behavioral Compliance Enhancement Treatment Sponsor: VA Office of Research and Development Recruiting
Condition: Urinary Tract Infections Interventions: Other: Longer therapy duration; Other: Shorter therapy duration Sponsor: VA Office of Research and Development Recruiting
Conditions: Functional Dysphonia; Voice Disorders; Dysphonia Interventions: Behavioral: VOICE Intervention Arm; Behavioral: Information-Only Arm Sponsors: University of Minnesota; National Institute on Deafness and Other Communication Disorders (NIDCD) Recruiting
Condition: Stress Intervention: Behavioral: ADS Plus Sponsors: Johns Hopkins University; University of Minnesota; National Institute on Aging (NIA) Recruiting
Conditions: Pleuropulmonary Blastoma; Sertoli-Leydig Cell Tumor; DICER1 Syndrome; Cystic Nephroma; Wilms Tumor; Pineoblastoma; Renal Sarcoma; Nodular Hyperplasia of Thyroid; Nasal Chondromesenchymal Hamartoma; Ciliary Body Medulloepithelioma; Neuroblastoma; Pituitary Cancer; Embryonal Rhabdomyosarcoma Intervention: Sponsors: Children's Hospitals and Clinics of Minnesota; Children's Research Institute; Washington University School of Medicine; ResourcePath, LLC; Beijing Children's Hospital; University of Cambridge; Emory University; Dana-Farber Cancer Institute Recruiting
Condition: Hematologic Malignancies Interventions: Biological: Haplo HCT <55 years old; Biological: Haplo HCT ≥55 years old; Drug: GVHD Prophylaxis; Biological: Haplo HCT ≥55 and < 65 years old; Biological: Haplo HCT ≥65 and ≤75 years old Sponsor: Masonic Cancer Center, University of Minnesota Recruiting
Conditions: Obesity, Childhood; Physical Activity; Food Intake; Rural Health Intervention: Behavioral: NU-HOME Intervention Sponsors: University of Minnesota; Allina Health System; Minneapolis Heart Institute Foundation Recruiting
Conditions: Primary Graft Failure; Secondary Graft Failure Interventions: Drug: Fludarabine; Drug: Cyclophosphamide; Radiation: Total Body Irradiation; Biological: Hematopoietic stem cell infusion Sponsor: Masonic Cancer Center, University of Minnesota Recruiting
Conditions: Autologous Stem Cell Transplantation; Allogeneic Stem Cell Transplantation; Solid Tumors; Blood Cancers Intervention: Sponsor: Center for International Blood and Marrow Transplant Research Recruiting
Condition: Amputation Interventions: Device: Prosthetic Foot Emulator; Device: Commercially available prosthetic feet Sponsors: Seattle Institute for Biomedical and Clinical Research; VA Puget Sound Health Care System; Minneapolis Veterans Affairs Medical Center; Brooke Army Medical Center; Stanford University; University of Washington Recruiting
Conditions: Acute Pain; Low Back Pain, Mechanical Interventions: Behavioral: Supported-Self Management (SSM); Other: Spinal Manipulation Therapy (SMT); Combination Product: SMT + SSM; Drug: Standard Medical Care (SMC) Sponsors: University of Minnesota; University of Pittsburgh; University of Washington; University of North Texas Health Science Center; Oregon Health and Science University; Duke University Recruiting
Condition: Idiopathic Nephrotic Syndrome Interventions: Behavioral: Standard of Care; Behavioral: UrApp Sponsors: Emory University; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Recruiting
Conditions: PTSD; Posttraumatic Stress Disorder Interventions: Drug: Ketamine; Drug: Placebo Sponsors: VA Office of Research and Development; The University of Texas Health Science Center at San Antonio; Brooke Army Medical Center; Minneapolis Veterans Affairs Medical Center Recruiting
Condition: Posttraumatic Stress Disorder Interventions: Behavioral: Family Supported Prolonged Exposure; Behavioral: Standard Prolonged Exposure Sponsor: VA Office of Research and Development Recruiting
Condition: Cognition Interventions: Behavioral: Cognitive Assessments (Phase 1); Behavioral: Cognitive Battery A (Phase 2); Behavioral: Cognitive Battery B (Phase 2); Behavioral: Cognitive Battery C (Phase 2) Sponsors: University of Minnesota; University of California, San Francisco; Posit Science Corporation Recruiting
Condition: Ureteral Stones Interventions: Procedure: Ureteral stone removal; Procedure: Asymptomatic kidney stones and ureteral stone removed Sponsors: Indiana Kidney Stone Institute; University of Washington Medical Center Department of Urology (Seattle, WA); VA Puget Sound Health Care System Recruiting
Conditions: Early-Stage Breast Carcinoma; Invasive Breast Carcinoma Interventions: Drug: Retinoid 9cUAB30; Procedure: Therapeutic Conventional Surgery Sponsor: National Cancer Institute (NCI) Recruiting
Conditions: Gulf War Illness; Chronic Fatigue; Ubiquinol; Coenzyme Q10 Interventions: Drug: Ubiquinol; Drug: Placebo Sponsor: VA Office of Research and Development Recruiting
Condition: Mesothelioma, Malignant Interventions: Drug: Nivolumab; Drug: Ramucirumab Sponsors: Arkadiusz Z. Dudek, MD; HealthPartners Institute Regions Cancer Care Center; Eli Lilly and Company; Bristol-Myers Squibb Recruiting
Condition: Cystic Fibrosis Related Diabetes Intervention: Sponsors: Johns Hopkins University; Cystic Fibrosis Foundation; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Minnesota; Northwestern University Recruiting
Conditions: Post-traumatic Stress Disorder; Moral Injury; Traumatic Loss Interventions: Behavioral: Adaptive Disclosure for Moral Injury and Loss; Behavioral: Present Centered Therapy Sponsors: VA Office of Research and Development; Minneapolis Veterans Affairs Medical Center; San Francisco Veterans Affairs Medical Center; San Diego Veterans Healthcare System Recruiting
Conditions: Physical Inactivty; Wellbeing; Mindfulness Interventions: Behavioral: Mindful Movement; Other: Keys to Health & Wellbeing Sponsors: University of Minnesota; YMCA; National Center for Complementary and Integrative Health (NCCIH) Recruiting
Conditions: Estrogen Receptor-positive Breast Cancer; HER2/Neu Negative; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Drug: Palbociclib; Drug: Letrozole; Drug: Fulvestrant; Other: Questionnaire Administration; Other: Quality-of-Life Assessment Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Recruiting
Condition: Cytomegalovirus Infection Interventions: Device: DBS Self-Collection Kit; Other: Standard Control Strategy Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
Condition: Hypertension Interventions: Drug: Hydrochlorothiazide (HCTZ); Drug: Chlorthalidone Sponsor: VA Office of Research and Development Recruiting
Condition: Shoulder Pain Interventions: Device: WellClub; Behavioral: Standard Therapy Sponsors: University of Minnesota; Fairview Sports Physical Therapy Program Recruiting
Conditions: Cardiomyopathy; Coronary Artery Disease; Congestive Heart Failure; Myocardial Infarction Interventions: Device: Implantable Cardioverter Defibrillator; Other: Optimal Medical Therapy Sponsor: VA Office of Research and Development Recruiting
Condition: Metastatic Malignant Neoplasm in the Brain Interventions: Radiation: Single Fraction Stereotactic Radiosurgery; Radiation: Fractionated Stereotactic Radiosurgery; Procedure: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Recruiting
Conditions: Anatomic Stage I Breast Cancer AJCC v8; Anatomic Stage IA Breast Cancer AJCC v8; Anatomic Stage IB Breast Cancer AJCC v8; Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIA Breast Cancer AJCC v8; Anatomic Stage IIB Breast Cancer AJCC v8; Anatomic Stage III Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Anatomic Stage IIIB Breast Cancer AJCC v8; Anatomic Stage IIIC Breast Cancer AJCC v8; Cancer Fatigue; Cancer Survivor; Complete Remission; Prognostic Stage I Breast Cancer AJCC v8; Prognostic Stage IA Breast Cancer AJCC v8; Prognostic Stage IB Breast Cancer AJCC v8; Prognostic Stage II Breast Cancer AJCC v8; Prognostic Stage IIA Breast Cancer AJCC v8; Prognostic Stage IIB Breast Cancer AJCC v8; Prognostic Stage III Breast Cancer AJCC v8; Prognostic Stage IIIA Breast Cancer AJCC v8; Prognostic Stage IIIB Breast Cancer AJCC v8; Prognostic Stage IIIC Breast Cancer AJCC v8 Interventions: Drug: Bupropion Hydrochloride Controlled-release; Other: Placebo; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: Gary Morrow; National Cancer Institute (NCI) Recruiting
Conditions: Diffuse Large B-Cell Lymphoma; Double-Expressor Lymphoma; High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements; High Grade B-Cell Lymphoma, Not Otherwise Specified; Neoplastic Cells With Double Expression of MYC and BCL2 Proteins Present Interventions: Drug: Cyclophosphamide; Drug: Doxorubicin; Drug: Doxorubicin Hydrochloride; Drug: Etoposide; Drug: Prednisone; Biological: Rituximab; Drug: Venetoclax; Drug: Vincristine; Drug: Vincristine Sulfate Sponsor: National Cancer Institute (NCI) Recruiting
Conditions: Skin Squamous Cell Carcinoma; Metastatic Skin Cancer Interventions: Drug: Avelumab; Drug: Cetuximab Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI) Recruiting
Conditions: Glioblastoma; Radiotherapy; Complications; Cognitive Decline; Chemoradiation Intervention: Drug: Ramipril Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI) Recruiting
Conditions: Cardiotoxicity; HER2/Neu Positive; Metastatic Malignant Neoplasm in the Brain; Recurrent Breast Carcinoma; Stage IV Breast Cancer AJCC v6 and v7 Interventions: Drug: Carvedilol; Other: Laboratory Biomarker Analysis; Other: Patient Observation Sponsors: Southwest Oncology Group; National Cancer Institute (NCI) Recruiting
Conditions: Ductal Breast Carcinoma; Invasive Breast Carcinoma; Lobular Breast Carcinoma; Medullary Breast Carcinoma; Stage II Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Tubular Breast Carcinoma Interventions: Radiation: Radiation Therapy; Other: Questionnaire Administration; Other: Quality-of-Life Assessment; Other: Laboratory Biomarker Analysis; Radiation: Hypofractionated Radiation Therapy Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Canadian Cancer Trials Group Recruiting
Conditions: Anxiety; Depressive Symptoms; Sleep Disturbance; Recurrent Disease; Fatigue; Quality of Life; Cancer Interventions: Other: Severe Anxiety/depression: High Intensity Stepped Care; Other: Moderate Anxiety/depression: Low Intensity Stepped care; Other: Enhanced Usual Care Control Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI) Recruiting
Condition: Metastatic Castration Resistant Prostate Cancer Interventions: Drug: Rucaparib; Drug: Abiraterone acetate or Enzalutamide or Docetaxel Sponsors: Clovis Oncology, Inc.; Foundation Medicine Recruiting
Conditions: Invasive Breast Carcinoma; Stage 0 Breast Cancer AJCC v6 and v7; Stage I Breast Cancer AJCC v7; Stage IA Breast Cancer AJCC v7; Stage IB Breast Cancer AJCC v7; Stage II Breast Cancer AJCC v6 and v7; Stage IIA Breast Cancer AJCC v6 and v7; Stage IIB Breast Cancer AJCC v6 and v7; Stage III Breast Cancer AJCC v7; Stage IIIA Breast Cancer AJCC v7; Stage IIIB Breast Cancer AJCC v7; Stage IIIC Breast Cancer AJCC v7; Triple-Negative Breast Carcinoma Interventions: Other: Laboratory Biomarker Analysis; Other: Patient Observation; Biological: Pembrolizumab; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Radiation: Radiation Therapy Sponsor: National Cancer Institute (NCI) Recruiting
Condition: Node Positive HER2 Negative Breast Cancer Interventions: Other: Placebo; Drug: Aspirin Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); United States Department of Defense; Bayer; Canadian Cancer Trials Group Recruiting
Conditions: Cognitive Dysfunction; Memory Impairment Interventions: Drug: Donepezil 5 mg; Drug: Placebo Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI) Recruiting
Condition: Desmoplastic Melanoma Interventions: Biological: Pembrolizumab; Procedure: Therapeutic Conventional Surgery Sponsor: National Cancer Institute (NCI) Recruiting
Conditions: Stage III Renal Cell Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7; Type 1 Papillary Renal Cell Carcinoma; Type 2 Papillary Renal Cell Carcinoma; Unresectable Renal Cell Carcinoma Interventions: Drug: Cabozantinib; Drug: Cabozantinib S-malate; Drug: Crizotinib; Drug: Savolitinib; Drug: Sunitinib; Drug: Sunitinib Malate Sponsors: National Cancer Institute (NCI); Canadian Cancer Trials Group Recruiting
Condition: Breast Carcinoma Interventions: Other: Health Education Program; Other: Weight Loss Intervention Sponsors: Alliance for Clinical Trials in Oncology; National Cancer Institute (NCI); Division of Cancer Control; NIH Biomarker, Imaging and Quality of Life Studies Funding Program (BIQSFP); Canadian Cancer Trials Group Recruiting